{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:01:54Z","timestamp":1772751714097,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ygyno.2011.09.007","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T18:42:04Z","timestamp":1320259324000},"page":"205-209","source":"Crossref","is-referenced-by-count":14,"title":["A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer"],"prefix":"10.1016","volume":"124","clinical-trial-number":[{"clinical-trial-number":"nct00489359","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jalid","family":"Sehouli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shokoufeh","family":"Manouchehrpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prafull","family":"Ghatage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cezary","family":"Szczylik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bauknecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine Y.","family":"Look","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gultan","family":"Oskay-\u00d6ezcelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.09.007_bb0110","series-title":"Global Cancer Facts & Figures 2007","author":"American Cancer Society","year":"2007"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(04)00002-9","article-title":"Focus on epithelial ovarian cancer","volume":"5","author":"Ozols","year":"2004","journal-title":"Cancer Cell"},{"issue":"2 Suppl. 6","key":"10.1016\/j.ygyno.2011.09.007_bb0015","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.seminoncol.2006.03.012","article-title":"Management of platinum-sensitive recurrent ovarian cancer","volume":"33","author":"Pfisterer","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0115","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0025","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2165\/11202640-000000000-00000","article-title":"Pemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancer","volume":"69","author":"Baldwin","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0030","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/(SICI)1097-4644(19970615)65:4<479::AID-JCB4>3.0.CO;2-L","article-title":"Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines","volume":"65","author":"Miotti","year":"1997","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1097-0215(19980105)75:1<125::AID-IJC19>3.0.CO;2-F","article-title":"Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells","volume":"75","author":"Corona","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0045","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/1078-0432.CCR-06-2393","article-title":"Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer","volume":"13","author":"Takimoto","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0050","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ejca.2008.12.013","article-title":"A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer","volume":"45","author":"Vergote","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5 Suppl. 12","key":"10.1016\/j.ygyno.2011.09.007_bb0055","first-page":"114","article-title":"The future role of carboplatin","volume":"21","author":"Ruckdeschel","year":"1994","journal-title":"Semin Oncol"},{"issue":"2 Suppl. 5","key":"10.1016\/j.ygyno.2011.09.007_bb0060","first-page":"27","article-title":"Review of therapeutic trials of carboplatin in lung cancer","volume":"16","author":"Bunn","year":"1989","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1525-1438.2007.01094.x","article-title":"Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up","volume":"18","author":"Sorbe","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0070","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0075","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1200\/JCO.2002.10.073","article-title":"Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma","volume":"20","author":"Hughes","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0080","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00280-009-1230-3","article-title":"A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer","volume":"66","author":"Sehouli","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Amer Stat Assoc"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0090","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1200\/JCO.2009.25.7519","article-title":"Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse","volume":"28","author":"Pujade-Lauraine","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.09.007_bb0095","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1200\/JCO.2008.17.0282","article-title":"Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer","volume":"26","author":"Matulonis","year":"2008","journal-title":"J Clin Oncol"},{"issue":"18S","key":"10.1016\/j.ygyno.2011.09.007_bb0120","first-page":"280s","article-title":"Randomized trials of combination chemotherapy (combo) versus monotherapy (mono) in relapsed ovarian carcinoma (ROC): a meta-analysis of published data","volume":"25","author":"Orlando","year":"2007","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2011.09.007_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1525-1438.2005.15355.x","article-title":"Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer","volume":"15","author":"Pfisterer","year":"2005","journal-title":"Int J Gynecol Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811007359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811007359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:58:08Z","timestamp":1543453088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811007359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0090825811007359"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.09.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}